Jalan, R., Turjanski, N., Taylor-Robinson, S. D., Koepp, M. J., Richardson, M. P., Wilson, J. A., Bell, J. D. & Brooks, D. J. (2000). Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut, 46(4), 546-552. https://doi.org/10.1136/gut.46.4.546

Jahanshahi, M., Jahanshahi, M., Jenkins, I. H., Brown, R. G., Marsden, C. D., Marsden, C. D., Passingham, R. E., Brooks, D. J. & Brooks, D. J. (1995). Self-initiated versus externally triggered movements: I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and parkinson's disease subjects. Brain, 118(4), 913-933. https://doi.org/10.1093/brain/118.4.913

Jabbari, E., Holland, N., Chelban, V., Jones, P. S., Lamb, R., Rawlinson, C., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Holton, J. L., Revesz, T., Warner, T. T., Lees, A. J. ... Morris, H. R. (2020). Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. JAMA Neurology, 77(3), 377-387. https://doi.org/10.1001/jamaneurol.2019.4347

Jabbari, E., Woodside, J., Tan, M. M. X., Pavese, N., Bandmann, O., Ghosh, B. C. P., Massey, L. A., Capps, E., Warner, T. T., Lees, A. J., Revesz, T., Holton, J. L., Williams, N. M., Grosset, D. G. & Morris, H. R. (2019). The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy. Movement Disorders, 34(9), 1307-1314. https://doi.org/10.1002/mds.27786

Ito, K., Nagano-Saito, A., Kato, T., Arahata, Y., Nakamura, A., Kawasumi, Y., Hatano, K., Abe, Y., Yamada, T., Kachi, T. & Brooks, D. J. (2002). Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[¹⁸F]fluoro-L-dopa PET study. Brain, 125(6), 1358-1365. https://doi.org/10.1093/brain/awf134

Ito, K., Morrish, P. K., Rakshi, J. S., Uema, T., Ashburner, J., Bailey, D. L., Friston, K. J. & Brooks, D. J. (1999). Statistical parametric mapping with ¹⁸F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 66(6), 754-758. https://doi.org/10.1136/jnnp.66.6.754

Ismail, R., Hansen, A. K., Parbo, P., Brændgaard, H., Gottrup, H., Brooks, D. J. & Borghammer, P. (2018). The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer's Disease. International Journal of Alzheimer's Disease, 2018, 6852303. Article 6852303. https://doi.org/10.1155/2018/6852303

Ismail, R., Parbo, P., Hansen, K. V., Schaldemose, J. L., Dalby, R. B., Tietze, A., Kjeldsen, P. L., la Cour, S. H., Qvist, P., Gottrup, H., Eskildsen, S. F. & Brooks, D. J. (2019). Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET Threshold. Journal of Neuroimaging, 29(4), 499-505. https://doi.org/10.1111/jon.12629

Ismail, R., Parbo, P., Madsen, L. S., Hansen, A. K., Hansen, K. V., Schaldemose, J. L., Kjeldsen, P. L., Stokholm, M. G., Gottrup, H., Eskildsen, S. F. & Brooks, D. J. (2020). The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study. Journal of Neuroinflammation, 17(1), Article 151. https://doi.org/10.1186/s12974-020-01820-6

Isaacs, J. D., Rakshi, J., Baker, R., Brooks, D. J. & Warrens, A. N. (2005). Chorea associated with thyroxine replacement therapy. Movement Disorders, 20(12), 1656-1657. https://doi.org/10.1002/mds.20603

Ikoma, Y., Edison, P., Ramlackhansingh, A., Brooks, D. J. & Turkheimer, F. E. (2013). Reference region automatic extraction in dynamic [(11)C]PIB. Journal of Cerebral Blood Flow and Metabolism, 33(11), 1725-31. https://doi.org/10.1038/jcbfm.2013.133

Hyder, F., Herman, P., Bailey, C. J., Møller, A., Globinsky, R., Fulbright, R. K., Rothman, D. L. & Gjedde, A. (2016). Uniform distributions of glucose oxidation and oxygen extraction in gray matter of normal human brain: No evidence of regional differences of aerobic glycolysis. Journal of Cerebral Blood Flow and Metabolism, 36(5), 903-916. https://doi.org/10.1177/0271678X15625349

Hyare, H., Ramlackhansingh, A., Gelosa, G., Edison, P., Rudge, P., Brandner, S., Brooks, D. J., Collinge, J. & Mead, S. (2012). 11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery & Psychiatry, 83(3), 340-1. https://doi.org/10.1136/jnnp.2010.233692

Hvingelby, V. S., Glud, A. N., Sørensen, J. C. H., Tai, Y., Andersen, A. S. M., Johnsen, E., Moro, E. & Pavese, N. (2022). Interventions to improve gait in Parkinson's disease: a systematic review of randomized controlled trials and network meta-analysis. Journal of Neurology, 269(8), 4068–4079 . https://doi.org/10.1007/s00415-022-11091-1

Hvingelby, V. S., Højholt Terkelsen, M., Johnsen, E. L., Møller, M., Danielsen, E. H., Henriksen, T., Glud, A. N., Tai, Y., Møller Andersen, A. S., Meier, K., Borghammer, P., Moro, E., Sørensen, J. C. H. & Pavese, N. (2022). Spinal cord stimulation therapy for patients with Parkinson's disease and gait problems (STEP-PD): study protocol for an exploratory, double-blind, randomised, placebo-controlled feasibility trial. BMJ Neurology Open, 4(2), Article e000333. https://doi.org/10.1136/bmjno-2022-000333

Hvingelby, V., Terkelsen, M. H., Valdemarsen, R. N., Andersen, A. S. M., Danielsen, E. H., Møller, M., Pavese, N. & Johnsen, E. L. (2023). Prevalence and severity of freezing of gait in a Danish cohort of people with Parkinson’s disease. Danish Medical Journal, 70(12), Article A03230209.

Hvingelby, V. S., Terkelsen, M. H., Valdemarsen, R. N., Andersen, A. S. M., Danielsen, E. H., Møller, M., Pavese, N. & Johnsen, E. (2023). Prevalence and severity of freezing of gait in a Danish cohort of people with Parkinsonʼs disease. Danish Medical Journal, 70(12), Article A03230209. https://ugeskriftet.dk/dmj/prevalence-and-severity-freezing-gait-danish-cohort-people-parkinsons-disease

Hvingelby, V. S. & Pavese, N. (2024). Surgical Advances in Parkinson’s Disease. Current Neuropharmacology, 22(6), 1033-1046. https://doi.org/10.2174/1570159X21666221121094343

Hvingelby, V., Carra, R. B., Terkelsen, M. H., Hamani, C., Capato, T., Košutzká, Z., Krauss, J. K., Moro, E., Pavese, N., Cury, R. G. & Gait Study Group (2024). A Pragmatic Review on Spinal Cord Stimulation Therapy for Parkinson's Disease Gait Related Disorders: Gaps and Controversies. Movement Disorders Clinical Practice, 11(8), 927-947. https://doi.org/10.1002/mdc3.14143

Hvilsom, A. S. T., Lillethorup, T. P., Iversen, P., Doudet, D. J., Wegener, G. & Landau, A. M. (2019). Cortical and striatal serotonin transporter binding in a genetic rat model of depression and in response to electroconvulsive stimuli. European Neuropsychopharmacology, 29(4), 493-500. https://doi.org/10.1016/j.euroneuro.2019.02.009

Husum, H., Aznar, S., Hoyer-Hansen, S., Larsen, M. H., Møller, A., Malthe, A. A. & Worthwein, G. (2006). Exacerbated loss of cell survival, neuropeptide Y-immunoreactive (IR) cells, and serotonin-IP fiber lengths in the dorsal hippocampus of the aged flinders sensitive line "depressed" rat: Implications for the pathophysiology of depression? J Neurosci Res., 84(6), 1292-1302.

Huo, W., Angeles, P., Tai, Y. F., Pavese, N., Wilson, S., Hu, M. T. & Vaidyanathan, R. (2020). A Heterogeneous Sensing Suite for Multisymptom Quantification of Parkinson's Disease. I E E E Transactions on Neural Systems and Rehabilitation Engineering, 28(6), 1397-1406. Article 9064818. https://doi.org/10.1109/TNSRE.2020.2978197

Hume, S. P., Luthra, S. K., Brown, D. J., Opacka-Juffry, J., Osman, S., Ashworth, S., Myers, R., Brady, F., Carroll, F. I., Kuhar, M. J. & Brooks, D. J. (1996). Evaluation of [¹¹C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. Nuclear Medicine and Biology, 23(3), 377-384. https://doi.org/10.1016/0969-8051(96)00019-4

Hu, M. T. M., Scherfler, C., Khan, N. L., Hajnal, J. V., Lees, A. J., Quinn, N., Wood, N. W. & Brooks, D. J. (2006). Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease. Movement Disorders, 21(3), 299-305. https://doi.org/10.1002/mds.20702

Hu, M. T. M., Chaudhuri, K. R., Jorosz, J., Yaguez, L. & Brooks, D. J. (2002). An imaging study of parkinsonism among African-Caribbean and Indian London communities. Movement Disorders, 17(6), 1321-1328. https://doi.org/10.1002/mds.10261

Hu, M. T. M., White, S. J., Chaudhuri, K. R., Morris, R. G., Bydder, G. M. & Brooks, D. J. (2001). Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. Journal of Neural Transmission, 108(5), 571-580. https://doi.org/10.1007/s007020170057

Hu, M. T. M., White, S. J., Herlihy, A. H., Chaudhuri, K. R., Hajnal, J. V. & Brooks, D. J. (2001). A comparison of ¹⁸F-dopa PET and inversion recovery MRI in the diagnosis of parkinson's disease. Neurology, 56(9), 1195-1200. https://doi.org/10.1212/WNL.56.9.1195

Hu, M. T. M., Taylor-Robinson, S. D., Chaudhuri, K. R., Bell, J. D., Labbé, C., Cunningham, V. J., Koepp, M. J., Hammers, A., Morris, R. G., Turjanski, N. & Brooks, D. J. (2000). Cortical dysfunction in non-demented Parkinson's disease patients. A combined ³¹P-MRS and ¹⁸FDG-PET study. Brain, 123(2), 340-352. https://doi.org/10.1093/brain/123.2.340

Hu, M. T. M., Taylor-Robinson, S. D., Ray Chaudhuri, K., Bell, J. D., Morris, R. G., Clough, C., Brooks, D. J. & Turjanski, N. (1999). Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: A proton MR spectroscopy study. Journal of Neurology Neurosurgery and Psychiatry, 67(1), 20-26. https://doi.org/10.1136/jnnp.67.1.20

Horsager, J., Knudsen, K., Andersen, K., Skjaerbaek, C., Fedorova, T., Geday, J., Kraft, J., Bech, E., Danielsen, E., Moller, M., Pavese, N., Brooks, D. & Borghammer, P. (2019). "Brain-first" vs. "body-first" Parkinson's disease is determined by RBD-status - a multi-modality imaging study. Movement Disorders, 34(S2), S796-S796. https://www.mdsabstracts.org/abstract/brain-first-vs-body-first-parkinsons-disease-is-determined-by-rbd-status-a-multi-modality-imaging-study/

Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J., Otto, M., Sommerauer, M., Danielsen, E. H., Bech, E., Kraft, J., Munk, O. L., Hansen, S. D., Pavese, N., Göder, R., Brooks, D. J. ... Borghammer, P. (2020). Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. Brain, 143(10), 3077-3088. https://doi.org/10.1093/brain/awaa238

Horsager, J., Okkels, N., Van Den Berge, N., Jacobsen, J., Schact, A., Munk, O. L., Vang, K., Bender, D., Brooks, D. J. & Borghammer, P. (2022). In vivo vesicular acetylcholine transporter density in human peripheral organs: an [ 18F]FEOBV PET/CT study. EJNMMI research, 12(1), Article 17. https://doi.org/10.1186/s13550-022-00889-9

Horsager, J., Okkels, N., Fedorova, T. D., Knudsen, K., Skjærbæk, C., Van Den Berge, N., Jacobsen, J., Munk, O. L., Danielsen, E. H., Bender, D., Brooks, D. J. & Borghammer, P. (2022). [ 18F]FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson's disease. Parkinsonism & Related Disorders, 104, 21-25. https://doi.org/10.1016/j.parkreldis.2022.09.016

Horsager, J., Okkels, N., Hansen, A. K., Damholdt, M. F., Andersen, K. H., Fedorova, T. D., Munk, O. L., Danielsen, E. H., Pavese, N., Brooks, D. J. & Borghammer, P. (2022). Mapping Cholinergic Synaptic Loss in Parkinson's Disease: An [18F]FEOBV PET Case-Control Study. Journal of Parkinson's Disease, 12(8), 2493-2506. https://doi.org/10.3233/JPD-223489

Hirani, E., Gillies, J., Karasawa, A., Shimada, J., Kase, H., Opacka-Juffry, J., Osman, S., Luthra, S. K., Hume, S. P. & Brooks, D. J. (2001). Evaluation of [4-O-methyl-¹¹C]KW-6002 as a potential PET ligand for mapping central adenosine A_2A receptors in rats. Synapse, 42(3), 164-176. https://doi.org/10.1002/syn.1110

Henrique Binda, K., Landau, A. M., Chacur, M., Brooks, D. J. & Cristiano Real, C. (2023). Treadmill exercise modulates nigral and hippocampal cannabinoid receptor type 1 in the 6-OHDA model of Parkinson's disease. Brain Research, 1814, Article 148436. https://doi.org/10.1016/j.brainres.2023.148436

Heneka, M. T., Carson, M. J., El Khoury, J., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., Herrup, K., Frautschy, S. A., Brown, G. C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G. C. ... Kummer, M. P. (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurology, 14(4), 388-405.

Helmich, R. C., Vaillancourt, D. E. & Brooks, D. J. (2018). The future of brain imaging in Parkinson's disease. Journal of Parkinson's Disease, 8(s1), S47-S51. https://doi.org/10.3233/JPD-181482

Hansen, A. K., Knudsen, K., Lillethorup, T. P., Landau, A. M., Parbo, P., Fedorova, T., Audrain, H., Bender, D., Østergaard, K., Brooks, D. J. & Borghammer, P. (2016). In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Brain, 139(7), 2039-2049. https://doi.org/10.1093/brain/aww098

Hansen, A. K., Damholdt, M. F., Fedorova, T. D., Knudsen, K., Parbo, P., Ismail, R., Østergaard, K., Brooks, D. J. & Borghammer, P. (2017). In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography. Movement Disorders, 32(6), 922-927. https://doi.org/10.1002/mds.26961

Hansen, A. K., Brooks, D. J. & Borghammer, P. (2017). MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([(18)F]-AV-1451) Binding. Molecular Imaging and Biology, 20(3), 356-360. https://doi.org/10.1007/s11307-017-1143-1

Hansen, A. K., Parbo, P., Ismail, R., Østergaard, K., Brooks, D. J. & Borghammer, P. (2020). Tau Tangles in Parkinson's Disease: A 2-Year Follow-Up Flortaucipir PET Study. Journal of Parkinson's Disease, 10(1), 161-171. https://doi.org/10.3233/JPD-191774

Hammers, A., Panagoda, P., Heckemann, R. A., Kelsch, W., Turkheimer, F. E., Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2008). [¹¹C]Flumazenil PET in temporal lobe epilepsy: Do we need an arterial input function or kinetic modeling? Journal of Cerebral Blood Flow and Metabolism, 28(1), 207-216. https://doi.org/10.1038/sj.jcbfm.9600515

Hammers, A., Asselin, M. C., Turkheimer, F. E., Hinz, R., Osman, S., Hotton, G., Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007). Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [¹¹C]diprenorphine test-retest data. NeuroImage, 38(1), 82-94. https://doi.org/10.1016/j.neuroimage.2007.06.035

Hammers, A., Asselin, M. C., Hinz, R., Kitchen, I., Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007). Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain, 130(4), 1009-1016. https://doi.org/10.1093/brain/awm012

Hammers, A., Chen, C. H., Lemieux, L., Allom, R., Vossos, S., Free, S. L., Myers, R., Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007). Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space. Human Brain Mapping, 28(1), 34-48. https://doi.org/10.1002/hbm.20254

Hammers, A., Koepp, M. J., Brooks, D. J. & Duncan, J. S. (2005). Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis. Epilepsia, 46(6), 944-948. https://doi.org/10.1111/j.1528-1167.2005.30904.x

Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J. & Duncan, J. S. (2003). Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Human Brain Mapping, 19(4), 224-247. https://doi.org/10.1002/hbm.10123

Hammers, A., Koepp, M. J., Richardson, M. P., Hurlemann, R., Brooks, D. J. & Duncan, J. S. (2003). Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain, 126(6), 1300-1318. https://doi.org/10.1093/brain/awg138

Hammers, A., Koepp, M. J., Hurlemann, R., Thom, M., Richardson, M. P., Brooks, D. J. & Duncan, J. S. (2002). Abnormalities of grey and white matter [¹¹C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain, 125(10), 2257-2271. https://doi.org/10.1093/brain/awf233

Hammers, A., Koepp, M. J., Free, S. L., Brett, M., Richardson, M. P., Labbé, C., Cunningham, V. J., Brooks, D. J. & Duncan, J. (2002). Implementation and application of a brain template for multiple volumes of interest. Human Brain Mapping, 15(3), 165-174. https://doi.org/10.1002/hbm.10016

Hammers, A., Koepp, M. J., Richardson, M. P., Labbé, C., Brooks, D. J., Cunningham, V. J. & Duncan, J. S. (2001). Central benzodiazepine receptors in malformations of cortical development: A quantitative study. Brain, 124(8), 1555-1565.

Hammers, A., Koepp, M. J., Labbé, C., Brooks, D. J., Thom, M., Cunningham, V. J. & Duncan, J. S. (2001). Neocortical abnormalities of [¹¹C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology, 56(7), 897-906. https://doi.org/10.1212/WNL.56.7.897

Hamdy, S., Rothwell, J. C., Brooks, D. J., Bailey, D., Aziz, Q. & Thompson, D. G. (1999). Identification of the cerebral loci processing human swallowing with H₂ ¹⁵O PET activation. Journal of Neurophysiology, 81(4), 1917-1926. https://doi.org/10.1152/jn.1999.81.4.1917

Hagell, P., Crabb, L., Pogarell, O., Schrag, A., Widner, H., Brooks, D. J., Oertel, W. H., Quinn, N. P. & Lindvall, O. (2000). Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease. Movement Disorders, 15(2), 224-229. https://doi.org/10.1002/1531-8257(200003)15:2<224::AID-MDS1004>3.0.CO;2-W

Hagell, P., Schrag, A., Piccini, P., Jahanshahi, M., Brown, R., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J. C., Odin, P., Wenning, G. K., Morrish, P., Gustavii, B., Björklund, A., Brooks, D. J., Marsden, C. D., Quinn, N. P. & Lindvall, O. (1999). Sequential bilateral transplantation in Parkinson's disease. Effects of the second graft. Brain, 122(6), 1121-1132. https://doi.org/10.1093/brain/122.6.1121

Hagell, P., Piccini, P., Björklund, A., Brundin, P., Rehncrona, S., Widner, H., Crabb, L., Pavese, N., Oertel, W. H., Quinn, N., Brooks, D. J. & Lindvall, O. (2002). Dyskinesias following neural transplantation in parkinson’s disease. Nature Neuroscience, 5(7), 627-628. https://doi.org/10.1038/nn863

Gundersen, H. J. G., Bagger, P., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., Møller, A., Nielsen, K., Nyengaard, J. R., Pakkenberg, B., Sørensen, F. B., Vesterby, A. & West, M. J. (1988). The new stereological tools: disector, fractionator, nucleator and point-sampled intercepts and their use in pathological research and diagnosis. APMIS Supplementum, 96, 857-881.

Grover, V. P. B., Pavese, N., Koh, S.-B., Wylezinska, M., Saxby, B. K., Gerhard, A., Forton, D. M., Brooks, D. J., Thomas, H. C. & Taylor-Robinson, S. D. (2012). Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. Journal of Viral Hepatitis, 19(2), e89-96. https://doi.org/10.1111/j.1365-2893.2011.01510.x

Grønborg, M., Johansen, T. E., Peters, D., Ahring, P. K., Drejer, J., Møller, A. & Jensen, L. H. (1999). Neuroprotection by a novel compound, NS521¹. The Journal of Pharmacology and Experimental Therapeutics, 290, 348-353.

Gredal, H., Thomsen, B. B., Boza-Serrano, A., Garosi, L., Rusbridge, C., Anthony, D., Møller, A., Finsen, B., Deierborg, T., Lambertsen, K. L. & Berendt, M. (2017). Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke. NeuroReport, 28(3), 134-140. https://doi.org/10.1097/WNR.0000000000000728

Grecchi, E., Doyle, O. M., Bertoldo, A., Pavese, N. & Turkheimer, F. E. (2014). Brain shaving: Adaptive detection for brain PET data. Physics in Medicine and Biology, 59(10), 2517-2534. https://doi.org/10.1088/0031-9155/59/10/2517

Grasby, P. M., Koepp, M. J., Gunn, R. N., Cunningham, V. J., Lawrence, A. D., Dagher, A., Jones, T., Brooks, D. J. & Bench, C. J. (1998). Evidence for dopamine release during a videogame using [¹¹C]Raclopride PET. NeuroImage, 7(4 PART II).

Goerres, G. W., Samuel, M., Jenkins, I. H. & Brooks, D. J. (1998). Cerebral control of unimanual and bimanual movements: An H₂ ¹⁵O PET study. NeuroReport, 9(16), 3631-3638. https://doi.org/10.1097/00001756-199811160-00014

Goerendt, I. K., Lawrence, A. D., Mehta, M. A., Stern, J. S., Odin, P. & Brooks, D. J. (2006). Distributed neural actions of anti-parkinsonian therapies as revealed by PET. Journal of Neural Transmission, 113(1), 75-86. https://doi.org/10.1007/s00702-005-0305-5

Goerendt, I. K., Lawrence, A. D. & Brooks, D. J. (2004). Reward Processing in Health and Parkinson's Disease: Neural Organization and Reorganization. Cerebral Cortex, 14(1), 73-80. https://doi.org/10.1093/cercor/bhg105

Goerendt, I. K., Messa, C., Lawrence, A. D., Grasby, P. M., Piccini, P. & Brooks, D. J. (2003). Dopamine release during sequential finger movements in health and Parkinson's disease: A PET study. Brain, 126(2), 312-325. https://doi.org/10.1093/brain/awg035

Glud, A. N., Jakobsen, S., Landau, A., Alstrup, A. K. O. & Sorensen, J. C. (2019). Visualization of intrathecal delivery by PET-imaging. Journal of Neuroscience Methods, 317, 45-48. https://doi.org/10.1016/j.jneumeth.2019.02.003

Gjerløff, T., Jakobsen, S., Nahimi, A., Munk, O. L., Bender, D., Alstrup, A. K. O., Vase, K. H., Brooks, D. J. & Borghammer, P. (2014). In Vivo Imaging of Human Acetylcholinesterase Density in Peripheral Organs Using 11C-Donepezil: Dosimetry, Biodistribution, and Kinetic Analyses. Journal of Nuclear Medicine, 55(11), 1818-24. https://doi.org/10.2967/jnumed.114.143859

Gjerløff, T., Fedorova, T. D., Knudsen, K., Munk, O. L., Nahimi, A., Jacobsen, S., Danielsen, E. H., Terkelsen, A. J., Hansen, J., Pavese, N., Brooks, D. J. & Borghammer, P. (2015). Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET. Brain, 138(3), 653-663. https://doi.org/10.1093/brain/awu369

Gjedde, A., Kumakura, Y., Cumming, P., Linnet, J. & Møller, A. (2010). Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proceedings of the National Academy of Sciences.

Gjedde, A., Rodell, A., Jakobsen, S., Alstrup, A. K. O., Møller, A., Dyve, S., Landau, A. M. & Doudet, D. (2010). Kinetic of Yohimbine binding in porcine brain in vivo. NeuroImage, (1), 225.

Gjedde, A., Aanerud, J., Peterson, E., Ashkanian, M., Iversen, P., Vafaee, M., Møller, A. & Borghammer, P. (2011). Variable ATP yields and uncoupling of oxygen consumption in human brain. Advances in Experimental Medicine and Biology, 701, 243-8. https://doi.org/10.1007/978-1-4419-7756-4_32

Giorgi, F. S., Biagioni, F., Galgani, A., Pavese, N., Lazzeri, G. & Fornai, F. (2020). Locus coeruleus modulates neuroinflammation in parkinsonism and dementia. International Journal of Molecular Sciences , 21(22), 1-21. Article 8630. https://doi.org/10.3390/ijms21228630

Giorgi, F. S., Martini, N., Lombardo, F., Galgani, A., Bastiani, L., Della Latta, D., Hlavata, H., Busceti, C. L., Biagioni, F., Puglisi-Allegra, S., Pavese, N. & Fornai, F. (2022). Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach. Journal of Neural Transmission, 129(4), 387-394. https://doi.org/10.1007/s00702-022-02486-5

Giorgi, F. S., Lombardo, F., Galgani, A., Hlavata, H., Della Latta, D., Martini, N., Pavese, N., Ghicopulos, I., Baldacci, F., Coi, A., Scalese, M., Bastiani, L., Keilberg, P., De Marchi, D., Fornai, F. & Bonuccelli, U. (2022). Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects. Brain Imaging and Behavior, 16(3), 1077-1087. https://doi.org/10.1007/s11682-021-00562-0

Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., Kaufmann, H., Klockgether, T., Lees, A., Poewe, W., Quinn, N., Revesz, T., Robertson, D., Sandroni, P., Seppi, K. & Vidailhet, M. (2008). Second consensus statement on the diagnosis of multiple system atrophy. Neurology, 71(9), 670-676. https://doi.org/10.1212/01.wnl.0000324625.00404.15

Gillies, J., Luthra, S. K., Brady, F. & Brooks, D. J. (1999). Radiosynthesis of the dopamine D₁ agonist R-(+)-[¹¹C]SKF 82957. - A simple [¹¹C]methylation? Journal of Labelled Compounds and Radiopharmaceuticals, 42(SUPPL. 1).

Gillies, J., Luthra, S. K., Brady, F., Karasawa, A., Shimada, J., Kase, H. & Brooks, D. J. (1999). Radiolabelling of KW-6002 with [¹¹C]iodomethane for studies of the adenosine A(2A) receptor in vivo. Journal of Labelled Compounds and Radiopharmaceuticals, 42(SUPPL. 1).

Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N. & Heywood, P. (2003). Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nature Medicine, 9(5), 589-595. https://doi.org/10.1038/nm850

Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N. & Heywood, P. (2006). Erratum: ADDENDUM: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (Nature Medicine (2003) 9 (589-595)). Nature Medicine, 12(4). https://doi.org/10.1038/nm0406-479

Giladi, N., Tal, J., Azulay, T., Rascol, O., Brooks, D. J., Melamed, E., Oertel, W., Poewe, W. H., Stocchi, F. & Tolosa, E. (2009). Validation of the Freezing of Gait Questionnaire in patients with Parkinson's disease. Movement Disorders, 24(5), 655-661. https://doi.org/10.1002/mds.21745

Ghadery, C., Best, L. A., Pavese, N., Tai, Y. F. & Strafella, A. P. (2019). PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases. Current Neurology and Neuroscience Reports, 19(7), Article 38. https://doi.org/10.1007/s11910-019-0951-x

Gersel Stokholm, M., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Bacher Svendsen, K., Garrido, A., Vilas, D., Fedorova, T. D., Santamaria, J., Møller, A., Gaig, C., Hiraoka, K., Brooks, D. J., Okamura, N., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder. European Journal of Neurology, 27(4), 644-652. https://doi.org/10.1111/ene.14127

Gerhard, A., Trender-Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P. & Brooks, D. J. (2006). In vivo imaging of microglial activation with [¹¹C]-PK11195 PET progresive supranuclear palsy. Movement Disorders, 21(1), 89-93. https://doi.org/10.1002/mds.20668

Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B. & Brooks, D. J. (2006). In vivo imaging of microglial activation with [¹¹C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiology of Disease, 21(2), 404-412. https://doi.org/10.1016/j.nbd.2005.08.002

Gerhard, A., Watts, J., Trender-Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K. & Brooks, D. J. (2004). In vivo imaging of microglial activation with [¹¹C](R -PK11195 PET in corticobasal degeneration. Movement Disorders, 19(10), 1221-1226. https://doi.org/10.1002/mds.20162

Gerhard, A., Banati, R. B., Goerres, G. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F., Good, C. D., Mathias, C. J., Quinn, N., Schwarz, J. & Brooks, D. J. (2003). [¹¹C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology, 61(5), 686-689. https://doi.org/10.1212/01.WNL.0000078192.95645.E6

Gelosa, G. & Brooks, D. J. (2012). The prognostic value of amyloid imaging. European Journal of Nuclear Medicine and Molecular Imaging, 39(7), 1207-19. https://doi.org/10.1007/s00259-012-2108-x

Gejl, M., Gjedde, A., Brock, B., Møller, A., van Duinkerken, E., Haahr, H. L., Hansen, C. T., Chu, P.-L., Stender-Petersen, K. L. & Rungby, J. (2018). Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial. Diabetologia, 61(3), 551-561. https://doi.org/10.1007/s00125-017-4502-1

Garvey, L. J., Pavese, N., Politis, M., Ramlackhansingh, A., Brooks, D. J., Taylor-Robinson, S. D. & Winston, A. (2014). Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS, 28(1), 67-72. https://doi.org/10.1097/01.aids.0000432467.54003.f7

Garvey, L. J., Pavese, N., Ramlackhansingh, A., Thomson, E., Allsop, J. M., Politis, M., Kulasegaram, R., Main, J., Brooks, D. J., Taylor-Robinson, S. D. & Winston, A. (2012). Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation. PLOS ONE, 7(7), e38980. https://doi.org/10.1371/journal.pone.0038980

Galgani, A., Vergallo, A., Campese, N., Lombardo, F., Pavese, N., Petrozzi, L., LoGerfo, A., Franzini, M., Cecchetti, D., Puglisi-Allegra, S., Busceti, C. L., Siciliano, G., Tognoni, G., Baldacci, F., Lista, S., Hampel, H., Fornai, F. & Giorgi, F. S. (2022). Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuum. Journal of Neurochemistry, 163(1), 40-52. https://doi.org/10.1111/jnc.15686

Galgani, A., Lombardo, F., Martini, N., Vergallo, A., Bastiani, L., Hampel, H., Hlavata, H., Baldacci, F., Tognoni, G., De Marchi, D., Ghicopulos, I., De Cori, S., Biagioni, F., Busceti, C. L., Ceravolo, R., Bonuccelli, U., Chiappino, D., Siciliano, G., Fornai, F. ... Giorgi, F. S. (2023). Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia. European Journal of Neurology, 30(1), 32-46. https://doi.org/10.1111/ene.15556

Galgani, A., Palermo, G., Lombardo, F., Martini, N., Bastiani, L., Vergallo, A., Tommasini, L., Bellini, G., Baldacci, F., Frosini, D., Tognoni, G., Gesi, M., Cademartiri, F., Fornai, F., Pavese, N., Ceravolo, R. & Giorgi, F. S. (2023). Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies. Current Alzheimer research, 20(4), 277-288. https://doi.org/10.2174/1567205020666230721144603

Galgani, A., Lombardo, F., Frijia, F., Martini, N., Tognoni, G., Pavese, N. & Giorgi, F. S. (2024). The degeneration of locus coeruleus occurring during Alzheimer’s disease clinical progression: a neuroimaging follow-up investigation. Brain Structure & Function, 229(5), 1317-1325. https://doi.org/10.1007/s00429-024-02797-1

Fuxe, K., Chadi, G., Agnati, L. F., Tinner, B., Rosén ., Janson, A. M., Møller, A., Cintra, A., Cao, Y., Goldstein, M., Lindahl, U., David, G., Ögren, O., Toffano, G., Baird, A. & Pettersson, R. F. (1994). Fibroblast growth factor-2, ganglioside GM1 and the trophic regulation of the basal ganglia. Focus on the nigrostriatal dopamine neurons. Pergamon Press, 62, 1-42.

Frisoni, G. B., Bocchetta, M., Chételat, G., Rabinovici, G. D., de Leon, M. J., Kaye, J., Reiman, E. M., Scheltens, P., Barkhof, F., Black, S. E., Brooks, D. J., Carrillo, M. C., Fox, N. C., Herholz, K., Nordberg, A., Jack, C. R., Jagust, W. J., Johnson, K. A., Rowe, C. C. ... ISTAART's NeuroImaging Professional Interest Area (2013). Imaging markers for Alzheimer disease: which vs how. Neurology, 81(5), 487-500. https://doi.org/10.1212/WNL.0b013e31829d86e8

Fricker, R. A., Torres, E. M., Hume, S. P., Myers, R., Opacka-Juffrey, J., Ashworth, S., Brooks, D. J. & Dunnett, S. B. (1997). The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience, 79(3), 711-721. https://doi.org/10.1016/S0306-4522(96)00657-4

Fredsø, N., Sabers, A., Toft, N., Møller, A. & Berendt, M. (2016). A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy. Veterinary Journal, 208, 44-9. https://doi.org/10.1016/j.tvjl.2015.10.018

Fox, T., Siderowf, A. D., Fernandez, H. H., Tanner, C. M., Postuma, R. B., Simon, D. K., Byrne, M., Lang, A. E., Brooks, D., Rascol, O., Tolosa, E., Poewe, W., Stocchi, F., Mollenhauer, B., Giladi, N., Hirschhorn, B., Cedarbaum, J. M., Nomikos, G., Fanning, L. ... Brys, M. (2020). Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson's Disease (1579). Neurology, 94(15).

Fleischhacker, W. W. & Brooks, D. J. (2003). Addiction. Mechanisms, phenomenology and treatment: Preface. Journal of Neural Transmission, Supplement, (66).

Fleischhacker, W. W. & Brooks, D. (2003). Neuropsychopharmacology: Preface. Journal of Neural Transmission, Supplement, (64).

Fjaeldstad, A., Kjaergaard, T., van Hartevelt, T. J., Moeller, A., Kringelbach, M. L. & Ovesen, T. (2015). Olfactory screening: Validation of Sniffin' Sticks in Denmark. Clinical Otolaryngology, 40(6), 545-550. https://doi.org/10.1111/coa.12405

Firbank, M. J., Yarnall, A. J., Lawson, R. A., Duncan, G. W., Khoo, T. K., Petrides, G. S., O'Brien, J. T., Barker, R. A., Maxwell, R. J., Brooks, D. J. & Burn, D. J. (2017). Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study. Journal of Neurology, Neurosurgery & Psychiatry, 88(4), 310-316. https://doi.org/10.1136/jnnp-2016-313918

Fern-Pollak, L., Whone, A. L., Brooks, D. J. & Mehta, M. A. (2004). Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease. Neuropsychologia, 42(14), 1917-1926. https://doi.org/10.1016/j.neuropsychologia.2004.05.004

Fernandes, H. M., Cabral, J., van Hartevelt, T. J., Lord, L. D., Gleesborg, C., Møller, A., Deco, G., Whybrow, P. C., Petrovic, P., James, A. C. & Kringelbach, M. L. (2019). Disrupted brain structural connectivity in Pediatric Bipolar Disorder with psychosis. Scientific Reports, 9(1), Article 13638. https://doi.org/10.1038/s41598-019-50093-4

Femminella, G. D., Ninan, S., Atkinson, R., Fan, Z., Brooks, D. J. & Edison, P. (2016). Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia? Journal of Alzheimer's Disease, 51(4), 1275-1289. https://doi.org/10.3233/JAD-150827

Femminella, G. D., Dani, M., Wood, M., Fan, Z., Calsolaro, V., Atkinson, R., Edginton, T., Hinz, R., Brooks, D. J. & Edison, P. (2019). Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume. Neurology, 92(12), E1331-E1343. https://doi.org/10.1212/WNL.0000000000007133

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2019). Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 20(1), Article 191. https://doi.org/10.1186/s13063-019-3259-x

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2020). Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 21, Article 660. https://doi.org/10.1186/s13063-020-04608-4

Femminella, G. D., Livingston, N. R., Raza, S., van der Doef, T., Frangou, E., Love, S., Busza, G., Calsolaro, V., Carver, S., Holmes, C., Ritchie, C. W., Lawrence, R. M., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E. ... Edison, P. (2021). Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects? Alzheimer's Research & Therapy, 13(1), Article 47. https://doi.org/10.1186/s13195-021-00784-w

Feeney, C., Scott LeBlanc, G., Raffel, J., Roberts, S., Coello, C., Jolly, A., Searle, G., Goldstone, A. P., Brooks, D. J., Nicholas, R. S., Trigg, W., Gunn, R. N. & Sharp, D. J. (2016). Kinetic analysis of the translocator protein positron emission tomography ligand [F-18]GE-180 in the human brain. European journal of nuclear medicine and molecular imaging, 43(12), 2201-2210. https://doi.org/10.1007/s00259-016-3444-z

Fedorova, T. D., Seidelin, L. B., Knudsen, K., Schacht, A. C., Geday, J., Pavese, N., Brooks, D. J. & Borghammer, P. (2017). Decreased intestinal acetylcholinesterase in early Parkinson disease; An 11C-donepezil PET study. Neurology, 88(8). https://doi.org/10.1212/WNL.0000000000003633

Fearnley, J. M., Revesz, T., Brooks, D. J., Frackowiak, R. S. J. & Lees, A. J. (1991). Diffuse Lewy body disease presenting with a supranuclear gaze palsy. Journal of Neurology Neurosurgery and Psychiatry, 54(2), 159-161. https://doi.org/10.1136/jnnp.54.2.159

Fast, R., Rodell, A., Gjedde, A., Mouridsen, K., Alstrup, A. K. O., Bjarkam, C. R., West, M. J., Berendt, M. & Møller, A. (2013). PiB fails to map amyloid deposits in cerebral cortex of aged dogs with canine cognitive dysfunction. Frontiers in Aging Neuroscience, 5(99), 1-11.

Farmen, K., Nissen, S. K., Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E., Pavese, N. & Romero-Ramos, M. (2021). Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder. Proceedings of the National Academy of Sciences, 118(10), Article e2020858118. https://doi.org/10.1073/pnas.2020858118

Fan, Z., Aman, Y., Ahmed, I., Chetelat, G., Landeau, B., Ray Chaudhuri, K., Brooks, D. J. & Edison, P. (2014). Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2014.06.016

Fan, Z., Brooks, D. J., Okello, A. & Edison, P. (2017). An early and late peak in microglial activation in Alzheimer's disease trajectory. Brain, 140(3), 792-803. https://doi.org/10.1093/brain/aww349

Fan, Z., Calsolaro, V., Atkinson, R. A., Femminella, G. D., Waldman, A., Buckley, C. J., Trigg, W., Brooks, D. J., Hinz, R. & Edison, P. (2016). Flutriciclamide (F-18-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein. Journal of Nuclear Medicine, 57(11), 1753-1759. https://doi.org/10.2967/jnumed.115.169078

Fan, Z., Okello, A. A., Brooks, D. J. & Edison, P. (2015). Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. Brain, 138(Pt 12), 3685-98. https://doi.org/10.1093/brain/awv288

Fan, Z., Dani, M., Femminella, G. D., Wood, M., Calsolaro, V., Veronese, M., Turkheimer, F., Gentleman, S., Brooks, D. J., Hinz, R. & Edison, P. (2018). Parametric mapping using spectral analysis for C-11-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects. European Journal of Nuclear Medicine and Molecular Imaging, 45(8), 1432-1441. https://doi.org/10.1007/s00259-018-3984-5

Evans, A. H., Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M., Brooks, D. J., Lees, A. J. & Piccini, P. (2006). Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Annals of Neurology, 59(5), 852-858. https://doi.org/10.1002/ana.20822

Eskildsen, S. F., Iranzo, A., Stokholm, M. G., Stær, K., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E., Østergaard, L. & Pavese, N. (2021). Impaired cerebral microcirculation in isolated REM sleep behaviour disorder. Brain : a journal of neurology, 144(5), 1498-1508. https://doi.org/10.1093/brain/awab054

Elmholdt, E.-M., Skewes, J. C., Dietz, M., Møller, A., Jensen, M. S., Roepstorff, A., Wiech, K. & Staehelin-Jensen, T. (2017). Reduced Pain Sensation and Reduced BOLD Signal in Parietofrontal Networks during Religious Prayer. Frontiers in Human Neuroscience, 11, Article 337. https://doi.org/10.3389/fnhum.2017.00337

Ellis, E. G., Meyer, G. M., Kaasinen, V., Corp, D. T., Pavese, N., Reich, M. M. & Joutsa, J. (2024). Multimodal neuroimaging to characterize symptom-specific networks in movement disorders. npj Parkinson's Disease , 10(1), Article 154. https://doi.org/10.1038/s41531-024-00774-3

Egefjord, L., Jensen, M. G., Møller, A., Brændgaard, H., Gottrup, H., Antropova, O., Møller, N., Poulsen, H., Gjedde, A., Brock, B. & Rungby, J. (2012). Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial. Danish Medical Journal, 59(10), A4519. http://www.danmedj.dk/portal/page/portal/danmedj.dk/dmj_forside/PAST_ISSUE/2012/DMJ_2012_10/A4519

Edison, P., Ahmed, I., Fan, Z., Hinz, R., Gelosa, G., Ray Chaudhuri, K., Walker, Z., Turkheimer, F. E. & Brooks, D. J. (2013). Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia. Neuropsychopharmacology, 38(6), 938-49. https://doi.org/10.1038/npp.2012.255

Edison, P., Hinz, R., Ramlackhansingh, A., Thomas, J., Gelosa, G., Archer, H. A., Turkheimer, F. E. & Brooks, D. J. (2012). Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans? NeuroImage, 60(3), 1716-23. https://doi.org/10.1016/j.neuroimage.2012.01.099

Edison, P., Carter, S. F., Rinne, J. O., Gelosa, G., Herholz, K., Nordberg, A., Brooks, D. J. & Hinz, R. (2013). Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. NeuroImage, 70, 423-33. https://doi.org/10.1016/j.neuroimage.2012.12.014

Edison, P. & Brooks, D. J. (2018). Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET. Journal of Alzheimer's Disease, 64(s1), S339-S351. https://doi.org/10.3233/JAD-179929

Edison, P., Hinz, R. & Brooks, D. J. (2011). Technical aspects of amyloid imaging for Alzheimer's disease. Alzheimer's Research & Therapy, 3(4), Article 25. https://doi.org/10.1186/alzrt87

Edison, P., Brooks, D. J., Turkheimer, F. E., Archer, H. A. & Hinz, R. (2009). Strategies for the generation of parametric images of [¹¹C]PIB with plasma input functions considering discriminations and reproducibility. NeuroImage, 48(2), 329-338. https://doi.org/10.1016/j.neuroimage.2009.06.079

Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., Rossor, M. & Brooks, D. J. (2008). Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiology of Disease, 32(3), 412-419. https://doi.org/10.1016/j.nbd.2008.08.001

Edison, P., Rowe, C. C., Rinne, J. O., Ng, S., Ahmed, I., Kemppainen, N., Villemagne, V. L., O'Keefe, G., Någren, K., Chaudhury, K. R., Masters, C. L. & Brooks, D. J. (2008). Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. Journal of Neurology, Neurosurgery & Psychiatry, 79(12), 1331-1338. https://doi.org/10.1136/jnnp.2007.127878

Edison, P., Archer, H. A., Hinz, R., Hammers, A., Pavese, N., Tai, Y. F., Hotton, G., Cutler, D., Fox, N., Kennedy, A., Rossor, M. & Brooks, D. J. (2007). Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study. Neurology, 68(7), 501-508. https://doi.org/10.1212/01.wnl.0000244749.20056.d4

Durcan, R., Wiblin, L., Lawson, R. A., Khoo, T. K., Yarnall, A. J., Duncan, G. W., Brooks, D. J., Pavese, N., Burn, D. J. & ICICLE-PD Study Group (2019). Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease. European Journal of Neurology, 26(7), 979-985. https://doi.org/10.1111/ene.13919

Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y., Brooks, D. J., Barker, R. A. & Burn, D. J. (2014). Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Movement Disorders, 29(2), 195-202. https://doi.org/10.1002/mds.25664

Duncan, G. W., Firbank, M. J., Yarnall, A. J., Khoo, T. K., Brooks, D. J., Barker, R. A., Burn, D. J. & O'Brien, J. T. (2016). Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Movement Disorders, 31(1), 103-110. https://doi.org/10.1002/mds.26312

Doudet, D., Dyve, S., Olsen Alstrup, A. K., Jakobsen, S., Simonsen, M., Møller, A., Videbech, P., Wegener, G., Gjedde, A. & Landau, A. M. (2010). Noradrenaline release: potential antidepressant mechanism of brain stimulation? NeuroImage.

Doudet, D., Dyve, S., Alstrup, A. K. O., Jakobsen, S., Simonsen, M., Møller, A., Videbech, P., Wegener, G., Gjedde, A. & Landau, A. M. (2010). Noradrenaline release: potential antidepressant mechanism of brain stimulation. NeuroImage, (1), 47.

Doppler, C. E. J., Kinnerup, M. B., Brune, C., Farrher, E., Betts, M., Fedorova, T. D., Schaldemose, J. L., Knudsen, K., Ismail, R., Seger, A. D., Hansen, A. K., Stær, K., Fink, G. R., Brooks, D. J., Nahimi, A., Borghammer, P. & Sommerauer, M. (2021). Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease. Brain : a journal of neurology, 144(9), 2732–2744. https://doi.org/10.1093/brain/awab236

Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J. & Brooks, D. J. (2003). Tremor in Parkinson's disease and serotonergic dysfunction: An ¹¹C-WAY 100635 PET study. Neurology, 60(4), 601-605. https://doi.org/10.1212/01.WNL.0000031424.51127.2B

Dodel, R., Spottke, A., Gerhard, A., Reuss, A., Reinecker, S., Schimke, N., Trenkwalder, C., Sixel-Döring, F., Herting, B., Kamm, C., Gasser, T., Sawires, M., Geser, F., Köllensperger, M., Seppi, K., Kloss, M., Krause, M., Daniels, C., Deuschl, G. ... Eggert, K. (2010). Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [¹¹C] (R)-PK11195 PET (MEMSA-trial). Movement Disorders, 25(1), 97-107. https://doi.org/10.1002/mds.22732

Devos, D., Labreuche, J., Rascol, O., Corvol, J. C., Duhamel, A., Delannoy, P. G., Poewe, W., Compta, Y., Pavese, N., Ruzička, E., Dušek, P., Post, B., Bloem, B. R., Berg, D., Maetzler, W., Otto, M., Habert, M. O., Lehericy, S., Ferreira, J. ... FAIRPARK-II Study Group (2022). Trial of Deferiprone in Parkinson's Disease. New England Journal of Medicine, 387(22), 2045-2055. https://doi.org/10.1056/NEJMoa2209254

Deuschl, G., Bain, P., Brin, M., Agid, Y., Benabid, L., Benecke, R., Berardelli, A., Brooks, D. J., Elble, R., Fahn, S., Findley, L. J., Hallett, M., Jankovic, J., Koller, W. C., Krack, P., Lang, A. E., Lees, A., Lucking, C. H., Marsden, C. D. ... Toloso, E. (1998). Consensus statement of the Movement Disorder Society on tremor. Movement Disorders, 13(SUPPL. 3), 2-23.

Dettmers, C., Fink, G. R., Lemon, R. N., Stephan, K. M., Passingham, R. E., Silbersweig, D., Holmes, A., Ridding, M. C., Brooks, D. J. & Frackowiak, R. S. J. (1995). Relation between cerebral activity and force in the motor areas of the human brain. Journal of Neurophysiology, 74(2), 802-815. https://doi.org/10.1152/jn.1995.74.2.802

DellaValle, B., Brix, G. S., Brock, B., Jensen, M. G., Landau, A. M., Møller, A., Rungby, J. & Larsen, A. (2016). Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats. Frontiers in Pharmacology, 7(NOV), 433. Article 433. https://doi.org/10.3389/fphar.2016.00433

Del Dotto, P., Pavese, N., Gambaccini, G., Bernardini, S., Metman, L. V., Chase, T. N. & Bonuccelli, U. (2001). Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study. Movement Disorders, 16(3), 515-520. https://doi.org/10.1002/mds.1112

Danielsen, E. H., Cumming, P., Andersen, F., Bender, D., Brevig, T., Falborg, L., Gee, A., Gillings, N. M., Hansen, S. B., Hermansen, F., Johansen, J., Johansen, T. E., Dahl-Jørgensen, A., Jørgensen, H. A., Meyer, M., Munk, O. L., Pedersen, E. B., Poulsen, P. H., Rodell, A. B. ... Møller, A. (2000). The DaNeX Study of Embryonic Mesencephalic Dopaminergic Tissue Grafted to a Minipig model of Parkinson's disease: Preliminary Findings of Effect of MPTP-Poisoning on Striatal Dopaminergic Markers. Cell Transplantation, 9(2), 247-259.

Dani, M., Brooks, D. J. & Edison, P. (2016). Tau imaging in neurodegenerative diseases. European journal of nuclear medicine and molecular imaging, 43(6), 1139-1150. https://doi.org/10.1007/s00259-015-3231-2

Dani, M., Brooks, D. J. & Edison, P. (2017). Suspected non-Alzheimer's pathology - Is it non-Alzheimer's or non-amyloid? Ageing Research Reviews, 36, 20-31. https://doi.org/10.1016/j.arr.2017.02.003

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Walker, Z., Morgan, R., Hinz, R., Biju, M., Kuruvilla, T., Brooks, D. J. & Edison, P. (2018). Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Brain, 141(9), 2740-2754. https://doi.org/10.1093/brain/awy188

Dani, M., Edison, P. & Brooks, D. J. (2016). Imaging biomarkers in tauopathies. Parkinsonism and Related Disorders, 22, S26-S28. https://doi.org/10.1016/j.parkreldis.2015.08.011

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Edginton, T., Hinz, R., Win, Z., Brooks, D. J. & Edison, P. (2019). Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer's Disease Subjects. Journal of Alzheimer's Disease, 70(2), 455-465. https://doi.org/10.3233/JAD-181168

Damholdt, M. F., Callesen, M. B. & Møller, A. (2014). Personality characteristics of depressed and non-depressed patients with Parkinson's Disease. Journal of Neuropsychiatry and Clinical Neurosciences, 26(4), 329-334. https://doi.org/10.1176/appi.neuropsych.13040085

Dall, A. M., Danielsen, E. H., Sørensen, J. C., Andersen, F., Møller, A., Zimmer, J., Gjedde, A., the DaNeX Group & Cumming, P. (2002). Quantitative [¹⁸F]Fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned Minipigs. Cell Transplantation, 11, 733-746.

Dall, A. M., Danielsen, E. H., Sørensen, J. C. H., Andersen, F., Møller, A., Zimmer, J., Gjedde, A. H. & Cumming, P. (2002). Quantitative [18F]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs. Cell Transplantation, 11(8), 733-46.

Dai, W., Zhou, H., Møller, A., Wei, P., Hu, K., Feng, K., Han, J., Li, Q. & Liu, X. (2022). Patients with Methamphetamine Use Disorder Show Highly Utilized Proactive Inhibitory Control and Intact Reactive Inhibitory Control with Long-Term Abstinence. Brain sciences, 12(8), Article 974. https://doi.org/10.3390/brainsci12080974

Dagø, L., Bonde, C., Peters, D., Møller, A., Bomholt, S. F., Hartz, B. P., Meyer, M., Drejer, J. & Grønborg, M. (2002). NS1231, a novel compound with neurotrophic-like effects in vitro and in vivo. Neurochemical, 81, 17-24.

Daglish, M. R. C., Williams, T. M., Wilson, S. J., Taylor, L. G., Eap, C. B., Augsburger, M., Giroud, C., Brooks, D. J., Myles, J. S., Grasby, P., Lingford-Hughes, A. R. & Nutt, D. J. (2008). Brain dopamine response in human opioid addiction. British Journal of Psychiatry, 193(1), 65-72. https://doi.org/10.1192/bjp.bp.107.041228

Dagher, A., Owen, A. M., Boecker, H. & Brooks, D. J. (2001). The role of the striatum and hippocampus in planning: A PET activation study in Parkinson's disease. Brain, 124(5), 1020-1032.

Dagher, A., Owen, A. M., Boecker, H. & Brooks, D. J. (1999). Mapping the network for planning: A correlational PET activation study with the Tower of London task. Brain, 122(10), 1973-1987. https://doi.org/10.1093/brain/122.10.1973

Dagher, A., Owen, A. M. & Brooks, D. J. (1997). Spatial planning in normal and parkisonian subjects: A PET study. NeuroImage, 5(4 PART II).

Cury, R. G., Pavese, N., Aziz, T. Z., Krauss, J. K., Moro, E. & the Neuromodulation of Gait Study Group from Movement Disorders Society (2022). Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease. npj Parkinson's Disease , 8(1), Article 8. https://doi.org/10.1038/s41531-021-00276-6

Cumming, P., Danielsen, E. H., Vafaee, M., Faldborg, L., Steffensen, E., Sørensen, J. C., Gillings, N., Bender, D., Marthi, K., Andersen, F., Munk, O., Smith, D., Møller, A. & Gjedde, A. (2001). Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts. Acta Neurologica Scandinavica, 103, 309-315.

Cintra, A., Lindberg, J., Chadi, G., Tinner, B., Møller, A., Gustafsson, J. Å., DeKloet, E. R., Oitzl, M., Nishikawa, K., Agnati, L. F. & Fuxe, K. (1994). Basic fibroblast growth factor and steroid receptors in the aging hippocampus of the brown norway rat: Immunocytochemical analysis in combination with stereology. Neurochem. Int., 25, 39-45.

Cintra, A., Aguirre, J. A., Finnman, U.-B., Hagman, M., Agnati, L. F., Höglund, C., Møller, A. & Fuxe, K. (1999). Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat. Neuroscience Letter, 274, 5-8.

Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A. A. ... Drzezga, A. (2020). Amyloid-PET and ¹⁸F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurology, 19(11), 951-962. https://doi.org/10.1016/S1474-4422(20)30314-8

Cheesman, A. L., Barker, R. A., Lewis, S. J. G., Robbins, T. W., Owen, A. M. & Brooks, D. J. (2005). Lateralisation of striatal function: Evidence from ¹⁸F-dopa PET in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 76(9), 1204-1210. https://doi.org/10.1136/jnnp.2004.055079

Chaudhuri, K. R., Rojo, J. M., Schapira, A. H. V., Brooks, D. J., Stocchi, F., Odin, P., Antonini, A., Brown, R. G. & Martinez-Martin, P. (2016). A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need (vol 8, e57221, 2013). P L o S One, 11(2), Article 0150130. https://doi.org/10.1371/journal.pone.0150130

Chaudhuri, K. R., Buxton-Thomas, M., Dhawan, V., Peng, R., Meilak, C. & Brooks, D. J. (2005). Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: Clinical follow up study of 13 cases. Journal of Neurology, Neurosurgery & Psychiatry, 76(1), 115-117. https://doi.org/10.1136/jnnp.2004.046292

Chaudhuri, K. R., Poewe, W. & Brooks, D. (2018). Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features. Movement Disorders, 33(6), 909-919. https://doi.org/10.1002/mds.27386

Chaudhuri, K. R., Hu, M. T. M. & Brooks, D. J. (2000). Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK. Movement Disorders, 15(1), 18-23. https://doi.org/10.1002/1531-8257(200001)15:1<18::AID-MDS1005>3.0.CO;2-Z

Chaudhuri, K. R., Richards, M. & Brooks, D. J. (1997). How far are we in understanding the cause of Parkinson's disease? Journal of neurology, neurosurgery, and psychiatry, 62(1). https://doi.org/10.1136/jnnp.62.1.104-a

Chaudhuri, K. R., Edwards, R., Scott, J., Brooks, D. J., Rees, A. & Pusey, C. D. (1993). Adult moyamoya disease. British Medical Journal, 307(6908), 852-854.

Chang, N. H. S., Kumakura, Y., Møller, A., Linnet, J., Bender, D., Doudet, D. J., Vafaee, M. S. & Gjedde, A. (2022). On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum. Brain Imaging and Behavior, 16(1), 355-365. https://doi.org/10.1007/s11682-021-00509-5

Chadi, G., Møller, A., Rosén, L., Janson, A. M., Agnati, L. A., Goldstein, M., Ögren, S.-O., Pettersson, R. F. & Fuxe, K. (1993). Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Experimental Brain Research, 97, 145-158.

Ceravolo, R., Piccini, P., Bailey, D. L., Jorga, K. M., Bryson, H. & Brooks, D. J. (2002). 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease. Synapse, 43(3), 201-207. https://doi.org/10.1002/syn.10034

Cenci, M. A. & Brooks, D. (2013). Bad news for neuroprotective therapies in PD? Journal of Parkinson's Disease, 3(3), 271-3. https://doi.org/10.3233/JPD-139001